Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Jeffrey Cohen - Ladenburg Scott Henry - Alliance Global Operator Ladies and gentlemen, thank you for standing by.
After losing some value lately, a hammer chart pattern has been formed for NanoX Imaging (NNOX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q2 2024 Earnings Conference Call August 20, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Scott Henry - AGP Ross Osborn - Cantor Fitzgerald Operator Good day, and thank you for standing by.
Nanox relies on AI to better interpret patients' scans. Reducing fraud for e-commerce companies is at the core of Riskified's business.
Nano-X Imaging is especially popular with analysts. Recursion Pharmaceuticals plans to report results from seven clinical studies over the next 18 months.
Here is how Nano-X Imaging Ltd. (NNOX) and Parsons (PSN) have performed compared to their sector so far this year.
Here is how Nano-X Imaging Ltd. (NNOX) and Seagate (STX) have performed compared to their sector so far this year.
NanoX Imaging (NNOX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
NanoX Imaging (NNOX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Here is how Nano-X Imaging Ltd. (NNOX) and Deluxe (DLX) have performed compared to their sector so far this year.
Nano-X Imaging stock rallied in February, but it's still down by about half over the past year. The FDA approved the company's flagship device over a year ago, but sales have been disappointing.
Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q1 2024 Earnings Conference Call May 28, 2024 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer Ran Daniel - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Jeff Cohen - Ladenburg Thalmann Operator Good day and thank you for standing by.